Steve Yang to join AstraZeneca as head of Asia and emerging markets R&D
This article was originally published in Scrip
Executive Summary
Dr Steve Yang has been named vice-president and head of R&D for Asia and emerging markets at AstraZeneca, effective 6 January. Dr Yang, previously a vice-president and head of Asia R&D for Pfizer, will continue to be based in Shanghai and report to Martin Mackay, AstraZeneca's R&D president. Part of his responsibilities at Pfizer included building up Asia-Pacific partnerships with academia, biotech ventures and contract research organisations to tap into regional research expertise (scripintelligence.com, 6 July 2010). Dr Yang is also a co-founder of the BayHelix group, a network of Chinese life science business leaders.